The Scotts Miracle-Gro Company (SMG) Stock Forecast
Data as of Oct 31, 2026Basic Materials · Current price $62.02 (+0.23%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 29, 2026 | Peter Grom | UBS | $67.00 | +8.0% |
| Jul 31, 2025 | Peter Grom | UBS | $68.00 | +9.7% |
| Jul 14, 2025 | Bill Chappell | Truist Financial | $80.00 | +29.0% |
| Dec 9, 2024 | Jonathan Matuszewski | Jefferies | $72.00 | +16.1% |
| Oct 16, 2024 | Bill Chappell | Truist Financial | $90.00 | +45.1% |
| Apr 5, 2024 | Bill Chappell | Truist Financial | $75.00 | +20.9% |
| Oct 17, 2023 | Joseph Altobello | Raymond James | $70.00 | +12.9% |
| Oct 17, 2023 | Michael Sison | Wells Fargo | $59.00 | -4.9% |
| Jul 17, 2023 | Jeffrey Zekauskas | J.P. Morgan | $80.00 | +29.0% |
| Jul 13, 2023 | Andrew Carter | Stifel Nicolaus | $72.00 | +16.1% |
| Feb 16, 2023 | Chris Carey | Wells Fargo | $100.00 | +61.3% |
| Jun 20, 2022 | Chris Carey | Wells Fargo | $115.00 | +85.4% |
Top Analysts Covering SMG
SMG vs Sector & Market
| Metric | SMG | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.22 | 2.34 | 2.41 |
| Analyst Count | 9 | 7 | 19 |
| Target Upside | +23.6% | +577.5% | +21.5% |
| P/E Ratio | 42.19 | -9.38 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-27 | $358M | $364M | $367M | 2 |
| 2027-03-27 | $1.42B | $1.45B | $1.46B | 2 |
| 2027-06-27 | $1.23B | $1.25B | $1.26B | 2 |
| 2027-09-27 | $349M | $354M | $357M | 2 |
| 2027-09-30 | $3.37B | $3.40B | $3.44B | 7 |
| 2027-12-27 | $368M | $374M | $377M | 2 |
| 2028-03-27 | $1.46B | $1.48B | $1.50B | 1 |
| 2028-06-27 | $1.26B | $1.28B | $1.29B | 1 |
| 2028-09-27 | $359M | $365M | $368M | 1 |
| 2028-09-30 | $3.49B | $3.49B | $3.49B | 6 |
| 2029-09-30 | $3.74B | $3.77B | $3.81B | 4 |
| 2030-09-30 | $3.93B | $3.96B | $4.00B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-27 | $-0.69 | $-0.69 | $-0.67 | 2 |
| 2027-03-27 | $4.16 | $4.25 | $4.30 | 4 |
| 2027-06-27 | $2.88 | $2.94 | $2.97 | 4 |
| 2027-09-27 | $-1.68 | $-1.66 | $-1.63 | 4 |
| 2027-09-30 | $4.53 | $4.86 | $5.21 | 5 |
| 2027-12-27 | $-0.68 | $-0.67 | $-0.66 | 4 |
| 2028-03-27 | $4.47 | $4.56 | $4.61 | 3 |
| 2028-06-27 | $3.11 | $3.18 | $3.21 | 3 |
| 2028-09-27 | $-1.66 | $-1.64 | $-1.61 | 3 |
| 2028-09-30 | $5.26 | $5.31 | $5.38 | 1 |
| 2029-09-30 | $7.02 | $7.09 | $7.18 | 1 |
| 2030-09-30 | $7.78 | $7.86 | $7.96 | 1 |
Frequently Asked Questions
What is the analyst consensus for SMG?
The consensus among 9 analysts covering The Scotts Miracle-Gro Company (SMG) is Buy with an average price target of $77.25.
What is the highest price target for SMG?
The highest price target for SMG is $115.00, set by Chris Carey at Wells Fargo on 2022-06-20.
What is the lowest price target for SMG?
The lowest price target for SMG is $59.00, set by Michael Sison at Wells Fargo on 2023-10-17.
How many analysts cover SMG?
9 analysts have issued ratings for The Scotts Miracle-Gro Company in the past 12 months.
Is SMG a buy or sell right now?
Based on 9 analyst ratings, SMG has a consensus rating of Buy (2.22/5) with a +23.6% upside to the consensus target of $77.25.
What are the earnings estimates for SMG?
Analysts estimate SMG will report EPS of $-0.69 for the period ending 2026-12-27, with revenue estimated at $364M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.